摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

33-hydroxy tritriacontanoic acid | 122166-19-2

中文名称
——
中文别名
——
英文名称
33-hydroxy tritriacontanoic acid
英文别名
omega-Hydroxytritriacontanoic acid;33-hydroxytritriacontanoic acid
33-hydroxy tritriacontanoic acid化学式
CAS
122166-19-2
化学式
C33H66O3
mdl
——
分子量
510.885
InChiKey
AQDOCDYUAFFGSN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    13.4
  • 重原子数:
    36
  • 可旋转键数:
    32
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.97
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Process for preparing hydroxycarboxylic acids
    申请人:UNILEVER PLC
    公开号:EP0711746A1
    公开(公告)日:1996-05-15
    A new synthesis of ω-hydroxy acids, which employs commercially available starting materials and lowers the cost of production. The process involves coupling a fatty acyl group by enamine chemistry, followed by a ring expansion and selective reduction of ketoacid.
    一种新的ω-羟基酸合成法,它采用了市场上可买到的起始原料,并降低了生产成本。该工艺包括用烯胺化学方法偶联脂肪酰基,然后进行扩环和选择性还原酮酸
  • Cosmetic compositions containing lactate dehydrogenase inhibitors
    申请人:UNILEVER PLC
    公开号:EP0722715B1
    公开(公告)日:2001-10-24
  • DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS
    申请人:Agrawal C. Mauli
    公开号:US20090123516A1
    公开(公告)日:2009-05-14
    Disclosed are medical devices comprising one or more surfaces, one or more SAM molecules attached to the one or more surfaces of the medical device, and one or more therapeutic agents attached to the one or more self-assembled monolayer molecules. Also disclosed are medical devices comprising one or more surfaces, one or more self-assembled monolayer molecules attached to the one or more surfaces of the medical device, one or more linkers comprising a first functional group and a second functional group, the first functional group attached to the self-assembled monolayer molecule and a therapeutic agent attached to the second functional group. The therapeutic agent may be attached to the SAM molecule via a linker. The present invention also concerns methods of administering a therapeutic agent to a subject, comprising contacting the subject with one of the medical devices set forth herein.
  • US5502226A
    申请人:——
    公开号:US5502226A
    公开(公告)日:1996-03-26
  • US5690944A
    申请人:——
    公开号:US5690944A
    公开(公告)日:1997-11-25
查看更多